Anzeige
Mehr »
Montag, 08.09.2025 - Börsentäglich über 12.000 News
Tokenisierung entfesselt: Republic führt die Ethereum-Revolution
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40GN1 | ISIN: CA4229102088 | Ticker-Symbol: HBP0
Frankfurt
08.09.25 | 08:06
0,860 Euro
+2,99 % +0,025
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
HELIX BIOPHARMA CORP Chart 1 Jahr
5-Tage-Chart
HELIX BIOPHARMA CORP 5-Tage-Chart

Aktuelle News zur HELIX BIOPHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
SaHelix BioPharma Corp (2): Helix ends review, drops GEM equity facility plan4
FrHelix BioPharma Corp.: Helix BioPharma Concludes Review, Will Not Proceed with Proposed Equity Draw-Down Subscription Facility with GEM2
23.08.Helix BioPharma Corp.: Helix Biopharma Corp. Announces Closing of Private Placement, in Preparation for Institutional Investment and NASDAQ Uplisting3
23.08.Helix BioPharma Corp (2): Helix BioPharma closes $1.66-million private placement2
14.08.Helix BioPharma Corp (2): Helix publishes article in Frontiers in Oncology4
13.08.Helix BioPharma Corp.: Helix Biopharma Corp. Announces Publication in Frontiers in Oncology on the Effects of L-DOS47 as Monotherapy in NSCLC3
17.06.Helix BioPharma Corp. Announces Filing of Interim Financial Statements as of and for the Nine Month Period Ended April 30, 20251
HELIX BIOPHARMA Aktie jetzt für 0€ handeln
03.06.Helix BioPharma Corp (2): Helix BioPharma appoints Babbar as CFO4
02.06.Helix BioPharma Corp. Announces CFO Appointment to Support Strategic Growth and Upcoming Milestones2
21.05.Helix BioPharma Corp (2): Helix BioPharma closes acquisitions of Laevoroc assets3
20.05.Helix BioPharma Corp.: Helix BioPharma (TSX: "HBP", OTC PINK: "HBPCD", FRANKFURT: "HBP0") Secures Pre-IND Candidates LEUMUNA and GEMCEDA in Strategic Acquisition from the Laevoroc Group1
15.05.Helix BioPharma Corp (2): Helix BioPharma signs capital raising agreement3
14.05.Helix BioPharma Corp. (HBP.TO) Signs Capital Raising Agreement with Kerentech Consulting Ltd.1
25.04.Helix BioPharma Corp (2): Helix Bio appoints Kandziora, Kourniaktis as execs2
24.04.Helix BioPharma Corp. Appoints New COO and Communications Director to Accelerate Growth and Deliver on its Mission Against Hard-to-Treat Cancers4
11.04.Helix BioPharma Corp (2): Helix BioPharma promotes Mehrling to CEO2
10.04.Helix BioPharma Corp. Appoints Dr. Thomas Mehrling as Chief Executive Officer to Drive Ambitious Clinical Development Plan1
03.04.Helix BioPharma Corp (2): Helix BioPharma hires ITG for market-making services1
03.04.Helix BioPharma Corp. Announces Engagement of Independent Trading Group to Provide Market-Making Services1
26.03.Helix BioPharma Corp (2): Helix BioPharma holders approve all matters at AGSM1
Weiter >>
23 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1